Abstract-During liver transplantation (LT) the glucose metabolism is effected by a crucial disturbance. The blood glucose level is extremely hard to control by conventional clinical protocols during this phase. Model based approach can enhance the blood glucose control during the anhepatic phase (absence of liver) and post-anhepatic phase. The physiological constants of validated clinical metabolic model were slightly modified based on previous studies. The model fitting errors and the sufficient capture of the blood glucose (BG) dynamic evinced the applicability of the model. However the sufficient per-patient estimation of endogenous production could more enhance the performance of the model based BG prediction.
I. INTRODUCTION
The liver plays a critical role maintaining metabolic balance. Nutrient rich blood from the intestines reaches first the liver through the portal vein. A primary function of the liver's to maintain glucose homeostasis, ensuring constant blood glucose (BG) in the peripheral organs and tissues [1] . Based on BG-level, the liver can uptake glucose from the blood for short, medium and long term storage. In a post-absorptive condition, it can be considered as the main source of the endogenous glucose production (EGP).
Liver transplantation (LT) can be divided into three main phases. The first step is called the pre-anhepatic phase (pre-AH). The second is the anhepatic phase (AH), and the third is the post-anhepatic phase (post-AH) or reperfusion step. Anhepatic phase refers to the absence of the liver. During LT, the absence of the liver causes enormous disturbance in BG homeostasis. As a consequence, BG variability increases during the surgery, particularly after reperfusion phase [2] , as also seen in Fig. 1 . The appropriate management of the metabolism in these phases towards lower BG, would promote recovery of LT patients [3] .
Given the dominant role of the liver, this article analyses LT data using a validated metabolic model. The goal is to determine the necessary modifications for accurate modeling of the metabolic system during LT. 
II. METHODS

A. Data
Data from 12 orthotopic liver transplanted (OLT) patients was obtained from the Transplantation and Surgery Clinic in Budapest. BG levels were measured by blood gas analysis. All insulin and glucose infusion data were recorded, as well as the times for the 3 major surgical steps. The average length of the anhepatic status was 80.4 ± 27 minutes. During the surgery a predictable significant increase occurs in BG independent of the administration of exogenous glucose or insulin [2] (Fig. 1) . Fig. 2 . BG trends (Mean ± SE) during the 3 surgery phases based on data from [4] , [5] , [6] (in accordance with the bar-order, the last three without SE were obtained from the same paper), the white face color bar represent the recent measurements. The measurements except the first bar show a high rate of correlation.
B. Metabolic model
The ICING (Intensive Control Insulin-Nutrition-Glucose) is a clinically validated metabolic model [7] . The model includes the glucose release by the liver (EGP ), and partially hepatic endogenous glucose clearance(p G ). The model parameters are listed in the Table I 
C. LT induced metabolic variation
A number of studies have analyzed the variation of glucose metabolism during liver transplantation. The majority focused on changes in EGP and endogenous glucose clearance [4] , [9] - [10] . Atchison et al. [2] reported an intensive increase of BG level during the AH-phase and an even more intensive increase after reperfusion. They showed it is independent of any exogenous glucose and insulin administration, consistent with the clinical measurements in Fig. 1 and [5] - [6] .
Determination of EGP can be divided into several groups. One part measured or estimated EGP analitically during 
D. Model parameter settings
In the 3 phases of LT surgery, the constants describing metabolic function, change as described in Table III These results can be inserted in the ICING model. In addition the model contains other parameters, that can be set to zero in the absence of the liver (clearance of insulin form plasma via the hepatic route the first pass hepatic insulin clearance and the endogenous insulin secration).
E. Model fitting design
Functions describing the model parameters can be divided in three phases to match thel physiological process and three main surgical steps. As the changes due to the surgical interventions are rapid, the changes in the parameters can be formulated by step functions. Over time, hepatic function was considered normal in the pre-anhepatic phase, and after reperfusion. Thus, the alterations were executed for the anhepatic phase.
Starting with EGP, its value in the AH phase decreases to 60%, and is reset to the baseline after the AH phase. The glucose distribution volume (V g ) decreases as well, as the veins are clamped in the begining of the AH phase. Clamping has a similar effect on the insulin distribution volume and limits exogenous insulin supply. As n l clearance of insulin from plasma via the hepatic route, in the absence of liver that function stops working. The pancreas is connected to the bloodstream through the liver. Thus, in absence of the liver it can be considered zero. As p g is for the insulin independent uptake of glucose, which is primarily in the liver, that function was also set to zero in the AH phase.
According to the above considered alterations the quantitative summary of the parameters is shown in Table IV. The modified model is then fit to the clinical data to ensure it captures all observed dynamics. The resulting errors we compared to the original unmodified model. 
III. RESULTS
The clinical measurements and the results of the model fitting are shown on the Fig. 3 . The time was divided into the following phases: A (pre-anhepatic), B (anhepatic), C (postanhepatic I) and D (post-anhepatic II). The lengths of the phases A and B were normalized for each patient to make a direct visual comparison. During the C and D phases the horizontal axis represents the elapsed time in hours. During the anhepatic (B) and reperfusion (C) peridos, the original ICING model could not capture the severely altered dynamics. However, the modified model matched the data better in Fig. 3 , where there is only a small small constant deviation in the B and the C phases. Thus EGP value was increased to 70% and the results in the Fig. 4 fit better with reduced error. Table V. shows the overall fitting errors that reflect this result. (Fig. 3 , Table. 4.) of the modified ICING model shows its applicability for use in BG management during LT. As a result of the change in physiological constants (EGP, Vg) according to the previous studies and the varying of the factors describing the glucose metabolism (p G , n L , u en ), the fitting of the model was able to capture the highly variable and dynamic BG dynamics in the anhepatic and post-anhepatic phases. Standard models without these changes could not manage these phases well.
The results also show, the model is appropriate for prediction and thus for BG control during LT. The recent fitting also helps to validate the assumption about the existence of nonhepatic EGP, which can be influenced by the kidney and other factors like progressive increase in release of the epinephrine. Further studies will focus on their estimation.
